Stock 688505 SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Shanghai S.E.

Equities

688505

CNE100004BN8

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
6.4 CNY -0.31% Intraday chart for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. -4.62% -30.66%
06-21 Fudan Zhangjiang Bio-Pharmaceutical Enrolls First Patient for Glioma Drug Trial MT
06-21 Shanghai Fudan Zhangjiang Bio-Pharmaceutical Terminates Libod Marketing Agreement MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Moderate to Severe Inflammatory Acne Vulgaris Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)
AQ
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : SUPPLEMENTAL CIRCULAR
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INDICATIVE ANNOUNCEMENT-FDA018 ANTIBODY DRUG CONJUGATE FOR INJECTION RECEIVED THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATION
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : Circular
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : PROXY FORM FOR CLASS MEETING OF HOLDERS OF H SHARES
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : (1) PROPOSED ADOPTION OF THE 2021 RESTRICTED INCENTIVE SCHEME (2) CONNECTED TRANSACTION - PROPOSED ISSUE AND GRANT OF NEW A SHARES UNDER THE INCENTIVE SCHEME PURSUANT TO SPECIFIC MANDATE
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : DISCLOSEABLE TRANSACTION-ACQUISITION OF EQUITY INTERESTS AND CAPITAL INCREASE IN TARGET COMPANY
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : ADJUSTMENTS IN THE ROLES OF MEMBERS OF THE NOMINATION COMMITTEE
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : UTILISATION OF PART OF THE OVER SUBSCRIPTION PROCEEDS FROM A SHARE OFFERING FOR PERMANENT REPLENISHMENT OF WORKING CAPITAL
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INSIDE INFORMATION-PROPOSED GRANT OF GENERAL MANDATE TO THE BOARD OF DIRECTORS TO REPURCHASE H SHARES
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INSIDE INFORMATION - ANNOUNCEMENT OF PRELIMINARY ANNUAL RESULTS FOR THE YEAR 2020
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INDICATIVE ANNOUNCEMENT ON OBTAINING DRUG REGISTRATION CERTIFICATE (PARECOXIB SODIUM)
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : Interim Report For the Six Months Ended 30 June 2020
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : CIRCULAR
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : ARTICLES OF ASSOCIATION
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : POLL RESULTS OF EXTRAORDINARY GENERAL MEETING, CLASS MEETING OF HOLDERS OF H SHARES AND CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : VOLUNTARY ANNOUNCEMENT-PRECAUTIONS DURING THE EPIDEMIC IN RELATION TO ATTENDANCE OF THE EXTRAORDINARY GENERAL MEETING, THE CLASS MEETING OF HOLDERS OF H SHARES AND THE CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : INSIDE INFORMATION-UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019
PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : POLL RESULTS OF EXTRAORDINARY GENERAL MEETING
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1349 Stock
  4. 688505 Stock
  5. News Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
  6. Press Releases